SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-052072
Filing Date
2017-02-22
Accepted
2017-02-22 16:10:56
Documents
2
Period of Report
2017-02-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d351256d8k.htm 8-K 16537
2 EX-99.1 d351256dex991.htm EX-99.1 28113
  Complete submission text file 0001193125-17-052072.txt   45890
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 17628457
SIC: 2836 Biological Products, (No Diagnostic Substances)